PM Group has expanded its Nordic operations with the opening of a new office in Copenhagen, targeting increased demand for life sciences and data centre projects across Denmark and the wider Nordic region.
The new Denmark hub will provide local support for complex projects in highly-regulated industries, including pharmaceutical manufacturing, biotechnology and mission critical infrastructure.
According to PM Group, the expansion reflects growing client demand in Denmark, particularly for projects focused on quality, sustainability and energy-efficient delivery.
The Copenhagen office will be led by Grant Sonne-Clifford, Portfolio Manager, who said the move would allow the company to strengthen local partnerships and respond more quickly to customer requirements.
PM Group said the new office strengthens its existing European network, which already includes locations in Ireland, Belgium, Germany, Poland and Switzerland.
The company has worked with major pharmaceutical and life sciences companies, including AstraZeneca, GSK, MSD, Pfizer, Eli Lilly and Company, and Alexion Pharmaceuticals, on complex life sciences and advanced manufacturing projects.
The company has continued expanding its international life sciences operations in recent years, including workforce growth in Benelux and new office investments in the US and Germany.
PM Group employs more than 4,000 people globally and delivers engineering, architecture, construction management and commissioning services for pharmaceutical, biotechnology, medical technology and advanced manufacturing facilities.
“Copenhagen is an important step in our European growth. Client demand, combined with Denmark’s focus on innovation, energy efficiency and responsible development, made this a natural decision for PM Group,” Andrea Brunetti, PM Group Operations Director of Europe.